CN209996812U - Liquiritigenin combined capsule - Google Patents
Liquiritigenin combined capsule Download PDFInfo
- Publication number
- CN209996812U CN209996812U CN201920517202.1U CN201920517202U CN209996812U CN 209996812 U CN209996812 U CN 209996812U CN 201920517202 U CN201920517202 U CN 201920517202U CN 209996812 U CN209996812 U CN 209996812U
- Authority
- CN
- China
- Prior art keywords
- capsule
- capsule body
- liquiritigenin
- lower half
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model provides a liquiritigenin's combination capsule, including capsule body for load flaky liquiritigenin, capsule body includes the first half utricule of and second half utricule, first half utricule and second half utricule detachable are connected, the second capsule body for load powdered liquiritigenin, the second capsule body includes second first half utricule and second half utricule, second first half utricule and second half utricule detachable are connected, the third capsule body for load liquid liquiritigenin, be equipped with the breach on the lateral wall of second capsule body, breach department passes through the rete and seals, the sealing bag is used for packing capsule body, second capsule body and third capsule body.
Description
Technical Field
The utility model relates to the technical field of capsules, in particular to a combined capsule of glycyrrhizin.
Background
The Glycyrrhrizae radix is dried root and rhizome H J of Glycyrrhiza uralensis Fisch (Glycyrrhiza uralensis Fisch.) of Glycyrrhiza genus of Leguminosae family, Glycyrrhiza inflata Bata1, Glycyrrhiza glabra L, and has effects of invigorating spleen, invigorating qi, clearing away heat and toxic materials, eliminating phlegm, relieving cough, relieving spasm, relieving pain, and harmonizing the drugs. The flavonoid component in the liquorice has various biological activities, and has obvious effects of resisting oxidation, cancer, tumor and the like besides the effects of diminishing inflammation, resisting bacteria, resisting allergy and the like. Modern pharmacological research shows that liquiritin, isoliquiritin, liquiritigenin and isoliquiritigenin are main effective components of licorice flavonoids.
Liquiritigenin (isoliquiritigenin), which is an isomer of isoliquiritigenin, is a white crystal with a molecular formula of C15H12O4, a molecular weight of 256.25, can be dissolved in organic solvents such as methanol, ethanol, n-propanol and isopropanol, and has a melting point: 206-208 ℃. Modern researches show that the liquiritin has the effects of resisting oxidation and ulcer, treating depressive psychosis and AIDS, assisting in treating diabetes and the like, and can be wiped on the skin of a human body to achieve the effects of health care and beauty.
The existing liquiritigenin is usually made into flaky liquiritigenin tablets, liquid liquiritigenin or powdered liquiritigenin powder, the flaky liquiritigenin tablets are used as medicines or health care products, the liquid liquiritigenin is used as health care products, the powdered liquiritigenin powder is used as food additives or health care products, however, the existing liquiritigenin packages only package forms of liquiritigenin, so that the application range of the liquiritigenin is limited by .
SUMMERY OF THE UTILITY MODEL
Aiming at the defects of the prior art, the utility model provides a combination capsule of kinds of liquiritigenin, it packs slice, liquid and likepowder liquiritigenin, lets the user select for use suitable liquiritigenin under different situation, increases the range of application of liquiritigenin.
The utility model provides a combined capsule of liquiritigenin, including capsule body for loading the flaky liquiritigenin, the capsule body includes the first half utricule and the second half utricule, the the first half utricule and the second half utricule detachable connection;
the second capsule body is used for loading powdery glycyrrhizin and comprises a second upper semi-capsule body and a second lower semi-capsule body, and the second upper semi-capsule body and the second lower semi-capsule body are detachably connected;
the third capsule body is used for loading liquiritigenin in a liquid state, a gap is arranged on the side wall of the second capsule body, and the gap is sealed through a film layer;
a sealing bag for packaging the th, second and third capsule bodies.
In the above technical solution, the utility model discloses can also do following improvement.
The preferable technical scheme is characterized in that the sealing bag comprises a bag body, an opening is formed in the side end of the bag body, the opening is sealed through a snap-fastener sealing strip, a placing plate is arranged in the sealing bag, and grooves matched with the th capsule body, the th capsule body and the third capsule body are formed in the placing plate respectively.
The preferable technical scheme is characterized in that an opening at the lower end of the th upper half bag body extends downwards to form a ring platform, an opening at the upper end of the th lower half bag body is provided with a ring groove, the length of the ring platform in the vertical direction is larger than the ring groove, the part extending into the th lower half bag body can be attached to the ring groove, the th upper half bag body is connected with the th lower half bag body through anti-theft paper, rings of easy-to-tear lines are arranged on the anti-theft paper, and the easy-to-tear lines are arranged opposite to the ring platform exposed out of the th lower half bag body.
The preferable technical scheme is characterized in that the end of the easy-to-tear line is separated from the anti-theft paper and forms a thread end.
The preferable technical scheme is characterized in that: the second upper half capsule body and the second lower half capsule body are rigid, the second upper half capsule body and the second lower half capsule body are in threaded connection, and the side wall of the second upper half capsule body is provided with a powder hole which is sealed through a plug.
The preferable technical scheme is characterized in that the end of the plug extending into the second upper half capsule body is provided with a sharp end.
The preferable technical scheme is characterized in that: the first upper semi-capsule body and the first lower semi-capsule body are made of transparent plastic, and scale marks connected with each other are arranged on the outer side walls of the first upper semi-capsule body and the first lower semi-capsule body.
The preferable technical proposal is characterized in that the outer end of the film layer is integrally formed with a catheter.
The preferable technical scheme is characterized in that: the thickness of the part of the film layer, which is opposite to the catheter, is smaller than the thickness of the peripheral side of the film layer, and the diameter of the sharp end is smaller than the pipe diameter of the catheter.
The preferable technical scheme is characterized in that: and the outer side wall of the third capsule body is provided with anti-skid grains.
Compared with the prior art, the utility model has the beneficial effects that the utility model discloses a set up capsule body, second capsule body and third capsule body, capsule body, second capsule body and third capsule body are used for packing flaky liquiritigenin respectively, powdered liquiritigenin and liquid liquiritigenin, flaky liquiritigenin piece can regard as medicine or health products to use, liquid liquiritigenin then is used for using as skin care products, the liquiritigenin powder of powder state then is used for using as food additive or health products for the user can choose suitable liquiritigenin under the different scenes, the range of application of liquiritigenin has been enlarged, also can use the family as the unit simultaneously, family member to different age brackets, use the liquiritigenin capsule of different grade type.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the prior art, reference will now be made briefly to the drawings which are needed in the description of the embodiments or the prior art.
Fig. 1 is a schematic structural diagram of a combined capsule of glycyrrhizins according to an embodiment of the present invention.
Fig. 2 is an exploded view of th capsule body according to an embodiment of the present invention.
Fig. 3 is a schematic structural diagram of an th capsule body according to an embodiment of the present invention.
Fig. 4 is an exploded view of a second capsule body according to an embodiment of the present invention.
Fig. 5 is a schematic structural diagram of a third capsule body according to an embodiment of the present invention.
Fig. 6 is a top view of a third capsule body according to an embodiment of the present invention.
Fig. 7 is a schematic structural diagram of a placing board according to an embodiment of the present invention.
In the figure, the respective symbols have the following meanings:
1. capsule body, 11, upper half capsule body, 111, ring platform, 12, lower half capsule body, 121, ring groove, 13, anti-theft paper, 131, easy-tear line, 132, thread end, 2, second capsule body, 21, second upper half capsule body, 211, powder hole, 22, second lower half capsule body, 23, plug, 231, sharp end, 3, third capsule body, 31, notch, 32, film layer, 321, catheter, 33, anti-slip line, 4, sealing bag, 41, snap fastener, 42, placing plate, 421 and groove.
Detailed Description
To further understand the contents, features and functions of the present invention, the following embodiments are illustrated and described in detail as follows:
referring to fig. 1 to 6, the present embodiment provides a combined capsule of glycyrrhizins, including a th capsule body 1 for loading tablet-shaped glycyrrhizins, wherein the th capsule body 1 includes a th upper half capsule body 11 and a th lower half capsule body 12, and the th upper half capsule body 11 and the th lower half capsule body 12 are detachably connected;
the second capsule body 2 is used for loading powdery glycyrrhizin, the second capsule body 2 comprises a second upper semi-capsule body 21 and a second lower semi-capsule body 22, and the second upper semi-capsule body 21 and the second lower semi-capsule body 22 are detachably connected;
the third capsule body 3 is used for loading liquiritigenin in liquid state, a gap 31 is arranged on the side wall of the second capsule body 2, and the gap 31 is sealed by a film layer 32;
a sealing bag 4, the sealing bag 4 being used for packing the th capsule body 1, the second capsule body 2 and the third capsule body 3.
The capsule body 1, the second capsule body 2 and the third capsule body 3 are arranged, the capsule body 1, the second capsule body 2 and the third capsule body 3 are respectively used for packaging sheet-shaped liquiritigenin, powdered liquiritigenin and liquid liquiritigenin, the sheet-shaped liquiritigenin can be used as a medicine or a health-care product, the liquid liquiritigenin can be used as a skin-care product or an anti-inflammatory medicine, the powder-state liquiritigenin powder can be used as a food additive or a health-care product, a user can open the capsule body 1 to take the sheet-shaped liquiritigenin according to the needs of the user, for example, when the liquiritigenin needs to be used as a medicine, when the liquiritigenin needs to be used as a food additive, the second capsule body 2 can be opened to pour out the powdered liquiritigenin, when the user needs to perform facial care, the liquid liquiritigenin can be wiped.
Referring to fig. 1 and 7, the sealing bag 4 includes a bag body, an opening is disposed at a side end of the bag body, the opening is sealed by a snap fastener 41 and a sealing strip, a placing plate 42 is disposed in the sealing bag 4, and grooves 421 respectively corresponding to the -th capsule body 1, the second capsule body 2 and the third capsule body 3 are disposed on the placing plate 42.
The snap buttons 41 are provided for preventing the external air from entering into the bag body, and the placing plate 42 is used for placing the th capsule body 1, the second capsule body 2 and the third capsule body 3.
Referring to fig. 1 and 3, a lower opening of the th upper half-bag body 11 extends downward to form a ring platform 111, an upper opening of the th lower half-bag body 12 is provided with rings of ring grooves 121, the length of the ring platform 111 in the vertical direction is greater than that of the ring grooves 121, a part of the ring platform 111 extending into the th lower half-bag body 12 can be attached to the ring grooves 121, the th upper half-bag body 11 and the th lower half-bag body 12 are connected through anti-theft paper 13, the anti-theft paper 13 is provided with rings of easy-to-tear lines 131, and the easy-to-tear lines 131 are arranged opposite to the ring platform 111 exposed out of the th lower half-bag body 12.
By matching the annular table 111 with the annular groove 121, the th upper half capsule body 11 and the th lower half capsule body 12 can be inserted into 0, the step is adhered to the th upper half capsule body 11 and the th lower half capsule body 12 through the anti-theft paper 13, the th upper half capsule body 11 and the th lower half capsule body 12 are tightly connected to , when a user needs to separate the th upper half capsule body 11 and the th lower half capsule body 12, the easy-to-tear line 131 needs to be torn, the anti-theft paper 13 and the easy-to-tear line 131 also have an anti-theft effect, and the tablet glycyrrhizin is prevented from being exchanged by others.
Referring to fig. 2 and 3, the end of the easy-tear line 131 is separated from the anti-theft paper 13 and forms a thread end 132.
A thread end 132 is provided to facilitate the tearing of the tear line 131 by the user.
Referring to fig. 4, the second upper half-bladder 21 and the second lower half-bladder 22 have rigidity, the second upper half-bladder 21 and the second lower half-bladder 22 are connected by a screw thread, a powder hole 211 is formed on a side wall of the second upper half-bladder 21, and the powder hole 211 is sealed by a plug 23.
When the user needs to use the powdered glycyrrhizin, the stopper 23 can be removed and the powdered glycyrrhizin can be poured out from the powder hole 211.
Referring to fig. 4, the end of the plug 23 extending into the second upper half capsule 21 is provided with a sharp end 231.
The sharp end 231 is used for puncturing the film layer 32, so that the user can pour out the liquiritigenin in the liquid state in the third capsule body 3 conveniently.
Referring to fig. 4, the second upper half-bag body 21 and the second lower half-bag body 22 are made of transparent plastic, and the outer side walls of the second upper half-bag body 21 and the second lower half-bag body 22 are provided with connected scale marks (not shown).
Here, the second upper capsule body 21 and the second lower capsule body 22 are transparent, so that the user can observe the stock of glycyrrhizin in the second capsule body 2 conveniently, and the scale marks are arranged so that the user can know the specific remaining value of glycyrrhizin conveniently.
Referring to fig. 5 and 6, the outer end of the membrane 32 is integrally formed with a catheter 321.
A liquid guide 321 is provided so that liquiritigenin in liquid form can be led out of the liquid guide 321.
Referring to fig. 6, the thickness of the portion of the membrane 32 facing the catheter 321 is smaller than the thickness of the peripheral side of the membrane 32, and the diameter of the sharp end 231 is smaller than the tube diameter of the catheter 321.
This is so arranged that the sharp end 231 can pass through the catheter 321 and more easily pierce the relatively thin membrane layer 32.
Referring to fig. 5, the outer side wall of the third capsule body 3 is provided with anti-slip lines 33.
The anti-slip pattern 33 that sets up facilitates the user and takes third capsule body 3, avoids third capsule body 3 to slide extruding third capsule body 3 simultaneously.
In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", "axial", "radial", "circumferential", and the like, indicate the orientation or positional relationship indicated based on the drawings, and are only for convenience of description and simplicity of description, and do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and therefore, should not be construed as limiting the present invention.
Thus, a feature defined as "", "second" may explicitly or implicitly include or more of that feature.
In the present invention, unless otherwise expressly stated or limited, the terms "mounted," "connected," "fixed," and the like shall be construed to , for example, as being fixedly connected, detachably connected, or in a body, mechanically connected, electrically connected, directly connected, indirectly connected through an intermediary, connected between two elements, or interacting between two elements.
In the present disclosure, unless expressly stated or limited otherwise, the term "on" or "under" a feature means that the term "on" or "under" a second feature directly contacts the term or indirectly contacts the term or indirectly contacts the term second feature through intervening media.A feature "on," "above" or "above" a second feature may mean that the term feature is directly above or obliquely above the second feature or merely means that the level of the characteristic is higher than that of the second feature.A feature "under," "below" and "under" a second feature may mean that the term feature is directly below or obliquely below the second feature or merely means that the level of the characteristic is lower than that of the second feature.
In the description of the present invention, reference to the description of the terms " embodiments", " embodiments", "examples", "specific examples", or " examples" or the like means that a particular feature, structure, material, or characteristic described in connection with the embodiments or examples is included in at least embodiments or examples of the present invention.
Claims (10)
- The combined capsule of glycyrrhizins is characterized by comprising a capsule body for loading flaky glycyrrhizins, wherein the capsule body comprises a upper half capsule body and a lower half capsule body, and the upper half capsule body is detachably connected with the lower half capsule body;the second capsule body is used for loading powdery glycyrrhizin and comprises a second upper semi-capsule body and a second lower semi-capsule body, and the second upper semi-capsule body and the second lower semi-capsule body are detachably connected;the third capsule body is used for loading liquiritigenin in a liquid state, a gap is arranged on the side wall of the second capsule body, and the gap is sealed through a film layer;a sealing bag for packaging the th, second and third capsule bodies.
- 2. The Liquiritigenin combination capsule of claim 1, wherein the sealed bag comprises a bag body, the side of the bag body is provided with an opening, the opening is sealed by a snap-seal strip, a placing plate is arranged in the sealed bag, and the placing plate is provided with grooves respectively matched with the capsule body, the second capsule body and the third capsule body.
- 3. The Liquiritigenin combination capsule of claim 1, wherein the bottom opening of the upper half capsule extends downward to form a ring platform, the top opening of the lower half capsule has rings of ring grooves, the length of the ring platform in the vertical direction is greater than the ring grooves, the part of the ring platform extending into the lower half capsule can be attached to the ring grooves, the upper half capsule is connected with the lower half capsule through anti-theft paper, the anti-theft paper has rings of easy-to-tear lines, and the easy-to-tear lines are opposite to the ring platform exposed out of the lower half capsule.
- 4. The Liquiritigenin combination capsule of claim 3, wherein the end of the tear line is separated from the anti-theft paper and forms a thread end.
- 5. The Liquiritigenin combination capsule of claim 4, wherein the second upper half capsule body and the second lower half capsule body are rigid, the second upper half capsule body and the second lower half capsule body are in threaded connection, and the side wall of the second upper half capsule body is provided with a powder hole, and the powder hole is sealed by a plug.
- 6. The Liquiritigenin combination capsule of claim 5, wherein the end of the plug extending into the second upper capsule half is provided with a sharp end.
- 7. The Liquiritigenin combination capsule of claim 6, wherein the second upper half-capsule body and the second lower half-capsule body are made of transparent plastic, and the outer side walls of the second upper half-capsule body and the second lower half-capsule body are provided with connected scale marks.
- 8. The Liquiritigenin combination capsule of claim 7, wherein a catheter is integrally formed at the outer end of the film.
- 9. The Liquiritigenin combination capsule according to claim 8, wherein the thickness of the portion of the film layer facing the catheter is less than the thickness of the peripheral side of the film layer, and the diameter of the sharp end is less than the diameter of the catheter.
- 10. The Liquiritigenin combination capsule of claim 9, wherein the outer side wall of the third capsule body is provided with anti-slip lines.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920517202.1U CN209996812U (en) | 2019-04-16 | 2019-04-16 | Liquiritigenin combined capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920517202.1U CN209996812U (en) | 2019-04-16 | 2019-04-16 | Liquiritigenin combined capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209996812U true CN209996812U (en) | 2020-01-31 |
Family
ID=69303949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201920517202.1U Expired - Fee Related CN209996812U (en) | 2019-04-16 | 2019-04-16 | Liquiritigenin combined capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209996812U (en) |
-
2019
- 2019-04-16 CN CN201920517202.1U patent/CN209996812U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4178917B2 (en) | Multi-chamber container | |
| CN209996812U (en) | Liquiritigenin combined capsule | |
| CN206730154U (en) | A kind of Pharmacy's Medicine box composed of several small boxes | |
| CN201768171U (en) | Separated medicament bottle used for holing liquid medicament | |
| CN204275022U (en) | The push button oral medicine bottle that a kind of convenience is quantitative | |
| CN209225767U (en) | A kind of portable internal medicine timing medicine box | |
| CN205148362U (en) | Ware is tailor to multi -functional tablet | |
| CN201524253U (en) | Medicine bottle convenient for taking medicine | |
| CN204367456U (en) | The tablet press machine of medicine | |
| CN203763501U (en) | Double-cavity medicine drinking bottle | |
| CN203793939U (en) | Pill preparation bottle | |
| CN109279181A (en) | A kind of protection label of bubble-cap type packaging | |
| CN104510614A (en) | Capsule-shaped drug classifying box | |
| CN206202965U (en) | A kind of Chinese herbal medicine active compound medicinal powder special packing bag | |
| CN201808768U (en) | Bottle cap provided with scale | |
| CN208974618U (en) | A kind of capsule composite packaging stiff sheet | |
| CN212140961U (en) | Medicinal capsule | |
| CN201414934Y (en) | Integrated drug-put box | |
| CN206914865U (en) | A kind of combination box for medicine | |
| CN206791895U (en) | A kind of anti-omission medicine box | |
| CN210205380U (en) | Medicine feeding device for internal medicine nursing | |
| CN201743937U (en) | Medicine-taking device for ward nursing | |
| CN205499689U (en) | Medicine granule storage device | |
| CN201290894Y (en) | Administration box capable of separately depositing tablet | |
| CN206508258U (en) | One kind quantitatively divides medicine device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200131 Termination date: 20210416 |